NCT07325864Recruiting
Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site
Source: ClinicalTrials.gov · Last updated 8 Jan 2026
Brief summary (registry, in English)
investigate the molecular differences between primitive lung cancer and the metastatic site.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 25 (estimated)
- First submitted
- 23 Dec 2025
- Start date
- 18 Dec 2025
- Primary completion date
- 30 Jun 2027
- Lead sponsor
- European Institute of Oncology
- Diseases
- Lung cancer
- NCT number
- NCT07325864
What you commit to
- Study type: Observational
- Planned participants: 25
- From 18 Dec 2025 to the primary completion date, 30 Jun 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Recent or ongoing severe or clinically significant infection.
Lab values
- Any other illness, metabolic disorder, physical examination, or laboratory findings that constitute a contraindication to study participation.
Age
- Women of childbearing age, pregnant or breastfeeding, or intending to become pregnant during the study.
Who the study is looking for
- patients aged ≥18 years fit enough to tolerate the surgical operation;
- the operative risk is considered low based on respiratory reserve and cardiac assessment;
- the patient has clearly expressed willingness to adhere;
- availability of pathological material for tumor DNA extraction and NGS execution.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Istituto Europeo di Oncologia Coordinator of this site? Confirm its status | Milan | Italy | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.